Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110668-110668
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Seasonality of brain function: role in psychiatric disorders
Rui Zhang, Nora D. Volkow
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 49
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Myles Corrigan, Aoife M. O’Rourke, Barry Moran, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 48
The role of cellular senescence in neurodegenerative diseases
Yating Wang, Kamil Kuča, You Li, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 8, pp. 2393-2408
Open Access | Times Cited: 17
Inflammation in obsessive–compulsive disorder: A literature review and hypothesis‐based potential of transcranial photobiomodulation
David Richer Araujo Coelho, Joshua D. Salvi, Willians Fernando Vieira, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Closed Access | Times Cited: 12
The Cellular Dysfunction of the Brain–Blood Barrier from Endothelial Cells to Astrocytes: The Pathway towards Neurotransmitter Impairment in Schizophrenia
Stefano Stanca, Martina Rossetti, Leona Bokulic Panichi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1250-1250
Open Access | Times Cited: 8
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders
Thays Calista Santiago, Larissa Parra, João V. Nani, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 2, pp. 138-155
Open Access | Times Cited: 19
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise
Jacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Schizophrenia Research Cognition (2024) Vol. 38, pp. 100328-100328
Open Access | Times Cited: 6
Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System
Hidekazu Sotoyama, Hisaaki Namba, Manavu Tohmi, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 372-372
Open Access | Times Cited: 15
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score
Fernando Facal, Manuel Arrojo, Mario Páramo, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024) Vol. 274, Iss. 7, pp. 1671-1679
Closed Access | Times Cited: 5
The neutrophil-lymphocyte ratio in first-episode medication-naïve patients with schizophrenia: A 12-week longitudinal follow-up study
Xiaobing Lu, Qianqian Sun, Ling Wu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110959-110959
Closed Access | Times Cited: 4
Inulin alleviates chronic ketamine-induced impairments in memory and prepulse inhibition by regulating the gut microbiota, inflammation, and kynurenine pathway
Zhilong Xu, Haoyang Lu, Chen Hu, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139503-139503
Closed Access
Is Low-Grade Inflammation Related to Cognitive Performance During a Sustained Attention Task in Depression? – A Case-Control Study
Bruno Pedraz‐Petrozzi, Eva Kathrin Lamadé, Nils Hübner, et al.
Biomarkers in Neuropsychiatry (2025) Vol. 12, pp. 100121-100121
Open Access
Serum metabolites and inflammation predict brain functional connectivity changes in Obsessive-Compulsive disorder
Guoqing Chen, Xiao Hong Zhao, Minyao Xie, et al.
Brain Behavior and Immunity (2025) Vol. 126, pp. 113-125
Closed Access
Correlation Between Monocyte Count, Monocyte–Lymphocyte Ratio, and Other Inflammatory Cells With Sleep and Psychiatric Symptoms in First-Episode Schizophrenia Patients
Chen Hu, Nan Du, Jingwei Li, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 373-381
Open Access
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation
Jacopo Sapienza, Giulia Agostoni, Federica Repaci, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
Biomarkers of endogenous mental disorders: the role of cortisol, extracellular DNA, BDNF, and cytokines in relation to disease stage and therapy
M. V. Kuzminova, Е. В. Семина, Y. A. Chayka
Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) (2025), Iss. 2, pp. 245-258
Closed Access
Sex-Specific Inflammatory Profiles Affect Neuropsychiatric Issues in COVID-19 Survivors
Mariagrazia Palladini, Mario Gennaro Mazza, B. Bravi, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 600-600
Open Access
Investigating the relationship between toll-like receptor activity, low-grade inflammation and cognitive deficits in schizophrenia patients – A mediation analysis
Saahithh Redddi Patlola, Laurena Holleran, Maria R. Dauvermann, et al.
Brain Behavior and Immunity (2025)
Closed Access
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
Unveiling the link between systemic inflammation markers and cognitive performance among older adults in the US: A population-based study using NHANES 2011–2014 data
Zheng Guo, Yulu Zheng, Geng Jian, et al.
Journal of Clinical Neuroscience (2023) Vol. 119, pp. 45-51
Open Access | Times Cited: 9
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The Impact of Oxidative Stress Biomarkers on Memory in Individuals With Schizophrenia and Antioxidant Use
Kadir Uludağ, Fatih Kara
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 477-500
Closed Access | Times Cited: 3
Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders
Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, Vicent Balanzá‐Martínez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110817-110817
Open Access | Times Cited: 8
Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1188-1188
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top